Medical Device Network on MSN

Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism

Out of 109 participants, 48 received early treatment, accounting for 44% of the trial population.
The American Journal of Managed Care

Post Hoc Analysis Findings Offer Guidance for Anemia Management in Myelofibrosis: Pankit Vachhani, MD

A post hoc analysis of the phase 3b JUMP trial supports the real-world use of ruxolitinib with anemia supportive care to maintain dosing and clinical outcomes in patients with myelofibrosis, offering ...
Healio

Post hoc analysis of PULSAR data shows sustained fluid control with Eylea HD

Please provide your email address to receive an email when new articles are posted on . BARCELONA, Spain — A post hoc analysis of PULSAR trial data showed sustained fluid control at 2 years with fewer ...
ascopubs.org

Post hoc analysis in patients (pts) with unresectable hepatocellular carcinoma (uHCC) who progressed to Child-Pugh B (CPB) liver function in the phase III REFLECT study of ...

Pembrolizumab (pembro) monotherapy for previously untreated advanced hepatocellular carcinoma (HCC): Phase II KEYNOTE-224 study. This is an ASCO Meeting Abstract from the 2021 Gastrointestinal Cancers ...

Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk ...

In a post hoc analysis, patients treated with roxadustat showed a durable and clinically meaningful improvement in transfusion independence (TI) ...
Healio

Post hoc analysis finds quick response to Xiidra

Please provide your email address to receive an email when new articles are posted on . At day 84, 55.3% of patients achieved a reduction in eye dryness of 60% or more. Patients with quick, dramatic ...
ascopubs.org

Post hoc analysis of sustained efficacy/tolerability of ≥12 cycles of omacetaxine mepesuccinate in chronic myeloid leukemia (CML).

Treatment response monitoring in chronic phase CML (CP-CML) patients receiving tyrosine kinase inhibitor (TKI) therapy in US Oncology network. This is an ASCO Meeting Abstract from the 2013 ASCO ...
Nature

Post-hoc analysis could give new life to the Alzheimer’s drug aducanumab

Amid desperate efforts to find a treatment for the neurodegenerative disease Alzheimer’s, the aducanumab saga continues, as a US Food and Drug Administration panel will determine whether a post-hoc ...
Medscape

Is the PREVENT Calculator Best for Determining CVD Risk? Insights From a Post Hoc Analysis of SPRINT Trial

A newer tool used to assess cardiovascular disease risk comes with both answers…and some questions. “These results were not surprising to us,” investigators Adam Bress, PharmD, MS, and Catherine ...
Nature

Daily self-reported behavioural efficacy records on hypertension digital therapeutics as digital metrics associated with the reduction in morning home blood pressure: post-hoc ...

Digital therapeutics for hypertension, proven effective in the HERB-DH1 trial, enable patients to record and track their daily actions and achievements to improve their lifestyles using an app.

Data Published in Interventional Pain Medicine Indicates Participants Who Received SPRINT PNS as Prescribed Were Three Times More Likely to Achieve Meaningful Pain Relief

SPR ® announced the publication of “Observations from the RESET Clinical Trial: A Post-Hoc Per Protocol Analysis of Clinical Outcomes with Percutaneous 60-Day Medial Branch PNS in Chronic Low Back ...